Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetic Patients With Peripheral Neuropathy

NCT04005287 is registered in ClinicalTrials.gov with WinSanTor, Inc as lead sponsor.

NCT NCT04005287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetic Patients With Peripheral Neuropathy
Lead sponsor
WinSanTor, Inc
Phase
Phase 2
Overall status
Completed
Start date
October 15, 2019
Completion date
December 15, 2021
Enrollment
58 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathies, painful, painful diabetic neuropathy, peripheral neuropathy